Technology Evaluation and Goal-Oriented Development of Pharmaceutical Products, Focusing on China's Emerging Innovation and Market Opportunities
Pharma-GPS, LLC is a US-based consulting company of PhD, MD, and MBA scientists and executives with decades of experience and expertise in pharmaceutical product development. We have strong ties to China and decades of technical, consumer marketing, global regulatory, and partnering experience in all phases and categories of pharmaceutical development (small molecule, biologics, botanicals, diagnostics).
- Technology Assessment/Technical Due Diligence. We provide an integrated, multidisciplinary technology evaluation to prepare companies for engaging potential partners or investors, or exploring opportunities in China.
- In/Out-Licensing Opportunities. We continually are seeking early-stage pharmaceutical/biotech licensing opportunities in China and companies with an interest in such acquisitions. We also facilitate market-entry into China for established or late-stage products.
- Goal-Oriented Development. We assist companies with design and execution of development programs (Regulatory, CMC, preclinical PK, toxicology, phase 1 clinical trials) that are customized to well-defined investor goals and/or exit strategies.
- Quality Evaluation of Chinese CROs. Our bilingual auditors with extensive US industry experience provide detailed GLP, GMP, and GCP compliance assessments, remediation plans, and training.
- Outsourcing Partner. On behalf of clients, we qualify CROs, negotiate prices, monitor studies, edit reports, and lower cultural barriers to promote effective business relationships.
By linking technology assessment and development guidance to commercial and investor objectives, and not being solely regulatory-driven, we are able to offer a unique perspective to enhance the value of your opportunities.